Abstract: There is provided a server that includes: an inspection item/main part correspondence table in which inspection items of the work machine and main parts of the work machine are associated; an inspection item list acquisition unit acquiring an inspection item list of the inspection target machine based on information about the inspection target machine received from the terminal; and a main part list acquisition unit acquiring a main part list in which the service parts are enumerated, being associated with the inspection items of the inspection target machine, based on the inspection item/main part correspondence table. The main part list acquisition unit transmits the acquired main part list to the terminal via the communication circuit as the selection information about the service parts.

Abstract: A marking structure where marking visibility is improved is provided. In a semiconductor device having a marking structure, the marking structure includes: a body for marking having a surface; a first mark group having a first concave portion formed in the surface; a second mark group having a second concave portion formed adjacent to the first concave portion in the surface. The first concave portion and the second concave portion differ in shape so that they may cause light reflection differently. Thus, visibility of the marking structure can be improved.

Abstract: An agent for suppressing elevation of blood GIP level, an agent for suppressing elevation of blood insulin level, an agent for lowering blood triglyceride level after meal ingestion and an agent for suppressing elevation of blood glucose level, these agents containing potassium polyglutamates as active ingredients.

Abstract: It is intended to provide a fungus of the genus Rhizopus having improved ability to produce lactic acid and a method for producing lactic acid using the fungus. The present invention provides a method for improving the lactate dehydrogenase activity of a fungus of the genus Rhizopus, comprising germinating a spore of a fungus of the genus Rhizopus in a culture medium containing a surfactant under specific conditions to obtain a mycelium, and a method for producing lactic acid using the mycelium of the fungus of the genus Rhizopus.

Abstract: An agent for suppressing postprandial elevation of blood insulin concentration, comprising a polyglutamic acid as an active ingredient.

Abstract: An agent for suppressing elevation of blood GIP concentration and an agent for preventing or improving obesity, each of which contains a polyglutamic acid as an active ingredient.

Abstract: An agent for suppressing elevation of a blood triglyceride concentration, comprising a polyglutamic acid as an active ingredient.

Abstract: A recombinant microorganism obtained by transferring, into a host microorganism capable of producing protein or polypeptide with increased productivity, a gene encoding a protein or polypeptide, and a method for producing a protein or polypeptide by use of the recombinant microorganism. The recombinant microorganism is prepared by transferring, to a mutant strain of microorganism from which any of Bacillus subtilis genes comA, yopO, treR, yvbA, cspB, yvaN, yttP, yurK, yozA, licR, sigL, mntR, glcT, yvdE, ykvE, slr, rocR, ccpA, yaaT, yyaA, yycH, yacP, hprK, rsiX, yhdK, and ylbO, or one or more genes functionally equivalent to any of these genes have been deleted or knocked out, a gene encoding a heterologous protein or polypeptide.

Abstract: An agent for suppressing elevation of blood GIP level, an agent for suppressing elevation of blood insulin level, an agent for lowering blood triglyceride level after meal ingestion and an agent for suppressing elevation of blood glucose level, these agents containing potassium polyglutamates as active ingredients.

Abstract: An agent for suppressing elevation of blood GIP concentration and an agent for preventing or improving obesity, each of which contains a polyglutamic acid as an active ingredient.

Abstract: An agent for suppressing elevation of a blood triglyceride concentration, comprising a polyglutamic acid as an active ingredient.

Abstract: An agent for suppressing postprandial elevation of blood insulin concentration, comprising a polyglutamic acid as an active ingredient.

Abstract: A display-image switching apparatus that switches the image shown in a display includes: an antilock brake system operation determination portion that determines whether an antilock brake system of the vehicle is operating; a provisional vehicle speed calculation portion that calculates a provisional vehicle speed that represents a speed at which the vehicle would travel if the antilock brake system were not operating; and a display-image switching portion that switches the displayed image based on the provisional vehicle speed if the antilock brake system is operating.

Abstract: A recombinant microorganism having poly-?-glutamic acid-producing ability, prepared by introducing a Bacillus subtilis pgsB gene or a gene functionally equivalent thereto, and a Bacillus subtilis pgsC gene or a gene functionally equivalent thereto, among a group of genes relating to synthesis of poly-?-glutamic acid, into a host microorganism, in which no Bacillus subtilis pgsA gene or a gene functionally equivalent thereto is being introduced into the host microorganism; and a method of producing poly-?-glutamic acid employing the recombinant microorganism.

Abstract: A display-image switching apparatus that switches the image shown in a display includes: an antilock brake system operation determination portion that determines whether an antilock brake system of the vehicle is operating; a provisional vehicle speed calculation portion that calculates a provisional vehicle speed that represents a speed at which the vehicle would travel if the antilock brake system were not operating; and a display-image switching portion that switches the displayed image based on the provisional vehicle speed if the antilock brake system is operating.

Abstract: A microorganism wherein one or more genes selected from the group of genes participating in sporulation in the middle to late stages of sporulation have been deleted or inactivated; and a process for producing a target product (a protein) by use the microorganism. No spore is formed when this microorganism is employed, thereby enabling production of a target product (a protein) while decreasing energy loss, production of a by-product and specific production speed to decrease unnecessary consumption of a medium. Moreover, the production period can be prolonged, whereby the target product (the protein) can be produced efficiently.

Abstract: The present invention provides a recombinant microorganism obtained by transferring, into a host microorganism which is capable of producing protein or polypeptide with increased productivity and which was identified by the present inventors, a gene encoding a protein or polypeptide, and a method for producing a protein or polypeptide by use of the recombinant microorganism.

Abstract: The present invention provides a recombinant microorganism obtained by transferring, into a host microorganism which is capable of producing protein or polypeptide with increased productivity and which was identified by the present inventors, a gene encoding a protein or polypeptide, and a method for producing a protein or polypeptide by use of the recombinant microorganism. The recombinant microorganism is prepared by transferring, to a mutant strain of microorganism from which any of at least one gene participating in membrane permeation of maltose has been deleted or knocked out, a gene encoding a heterologous protein or polypeptide.

Abstract: A recombinant microorganism obtained by transferring, into a host microorganism capable of producing protein or polypeptide with increased productivity, a gene encoding a protein or polypeptide, and a method for producing a protein or polypeptide by use of the recombinant microorganism. The recombinant microorganism is prepared by transferring, to a mutant strain of microorganism from which any of Bacillus subtilis genes comA, yopO, treR, yvbA, cspB, yvaN, yttP, yurK, yozA, licR, sigL, mntR, glcT, yvdE, ykvE, sir, rocR, ccpA, yaaT, yyaA, yycH, yacP, hprK, rsiX, yhdK, and yibO, or one or more genes functionally equivalent to any of these genes have been deleted or knocked out, a gene encoding a heterologous protein or polypeptide.

Abstract: The present invention relates to alkaline cellulase variants having an amino acid sequence which exhibits at least 95% homology with the amino acid sequence of SEQ ID NO: 2, wherein said alkaline cellulase variant is mutated to include at least one substitution at (a) position 10, (b) position 16, (c) position 22, (d) position 33, (e) position 39, (f) position 76, (g) position 109, (h) position 242, (i) position 263, (j) position 308, (k) position 462, (l) position 466, (m) position 468, (n) position 552, (o) position 564, or (p) position 608 in SEQ ID NO: 2, or at a position corresponding thereto, wherein said alkaline cellulase variant has alkaline cellulase activity. The present invention also relates to a gene encoding the variant; a vector containing the gene; a transformant containing the vector; and a detergent composition containing the alkaline cellulase variant.